脑部放疗，上午比下午敏感许多！
; Y8 a/ F2 M- m& m, @8 U9 K7 u, A% i. j) ]; R
0 e2 V/ r O) |' Z+ F% X N) _
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
% W+ F$ V- I: ~) ?+ r. M: w: W, uGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
9 q8 i& b6 F. g8 K9 @0 f) _" x, s: yRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
- E0 |; L6 `& hSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) X( \3 A) q3 V9 @) B; M8 A+ Q% E) x9 s6 W0 ^
Abstract. Y5 N: \8 x& U# i& R9 G! B9 Z3 m
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
: e k7 V% w2 C0 H E$ `) S$ N+ Z0 j6 C4 g' v
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.$ m: b& f3 N3 \1 [( D m# z
/ s3 @( n7 j! {" Y! x; v" aRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).6 i( n8 T- T5 a0 q
" `' O' A. L' h) }" YCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
" X1 a+ J5 n4 `; c
/ _$ E, |1 ^# U0 C; t' [ |
显身卡
